Physician profile
Grace Park
NPI 1407410004
$335.79
in general payments reported to CMS, 2019-2025
12 companies · $75.65 in 2025
The $75.65 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $89.87 · 2024: $170 · 2025: $75.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $81.61 | 2023-2025 | Wegovy |
| Ironshore Pharmaceuticals INC. | $34.59 | 2024 | |
| Merck Sharp & Dohme LLC | $33.55 | 2025 | Gardasil 9, Vaqta, Vaxneuvance |
| Biogen, INC. | $25.16 | 2024 | Spinraza |
| Avion Pharmaceuticals | $24.73 | 2023 | Methylphenidate Hydrochloride |
| Sanofi-Aventis U.S. LLC | $23.31 | 2024 | |
| Verrica Pharmaceuticals INC. | $22.74 | 2024 | Ycanth |
| Ironwood Pharmaceuticals, INC | $20.81 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $18.90 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $18.38 | 2023 | Bexsero |
| Pfizer INC. | $17.35 | 2023 | |
| Sanofi Pasteur INC. | $14.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.